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The placenta is a  homograft of unusual  tenure.  Several theories have been 
proposed in an attempt to explain this apparent homograft immunity. Basic to 
this  problem is  the  question  of trophoblastic  antigenicity.  One facet of  this 
question  is the transportation  of trophoblast into the maternal circulation in 
normal gestations.  Since these cells are of fetal origin the possibility of ABO 
isoimmunization occurring secondary to their transportation is evident.  Such 
an  immunologic  response  might  also  contribute  to  the  rapid  destruction  of 
these cells by the maternal host. 
Of equal interest is a  large body of statistical evidence which points to the 
selective intrauterine  loss of gestations associated with fetal-maternal incom- 
patibility within the ABO system. 
These questions have led us to study human placentas of various gestational 
ages for the presence of blood group substances by means of [mmunofluorescent 
(IF) staining. This paper presents the first phase of this work, the search for A 
and B substance in the trophoblast of the human term placenta. 
Materials and Makods 
Tissue.--AU tissue specimens  were obtained at the time of delivery or surgical removal and 
were quick-frozen  in egg albumin mounts in a dry ice-acetone mixture at --40°C as described 
by Rahman and Luttrell  (1). These specimens include representative areas of term placentas, 
blocks of adult  myometrium, cervix, stomach, and fetal kidney. These tissue blocks were 
stored at --20°C until sectioning in a eryostat immediately prior to incubation with the anti- 
serum. 
Blood Grouping and Sevretor Status.--The  ABO blood group of each tissue donor was 
ascertained by hemagglutination tube typing employing standard human antisera.  1 The AB 
secretor status  was determined with  saliva by means of the  hemagglutination inhibition 
method of Kabat (2). 
* This investigation was supported by United States Public Health  Service Grant  HD 
00509. 
~: Postdoctoral Trainee, United States Public Health Service Grant 2G-590. 
1 Dade Reagents, Inc., Miami, Florida. 
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Preparation of Antisera.-- 
Heterologous antiserum: Adult male albino rabbits (4 kg.) with naturally occurring anti-A 
were bled prior to immunization and the serum stored in small aliquots at  -20°C.  These 
rabbits were then inoculated intravenously with 3 ml of 3 times washed blood group  AI Rh- 
negative human erythrocytes on alternate days for a  total of 9 injections. The rabbits were 
bled either by ear vein or cardiac puncture 10 days after the last injection. In addition, rabbit 
antiserum to human A substance extracted from ovarian cyst fluid was generously provided 
by Dr. Harold Baer (3).2 These crude heterologous antisera were stored at -  20°C. 
Absorption and characterization of the sera were performed immediately prior to their use 
in immunofluorescent studies. The crude immune rabbit serum was heat-inactivated at 56°C 
for 30 minutes.  Absorption with guinea pig kidney suspension  3  (5  ml/ml antiserum)  was 
carried out for 20 minutes at 4°C and then at room temperature for 30 minutes. The resulting 
superuate was absorbed with blood group O amnion powder (100 mg/ml of antiserum) for 1 
hour at room temperature. The supernate was recovered by high-speed centrifugation at 14,000 
~e~ for 20 minutes at 7°C.  Using 4 times washed human blood group O and B  Rh-positive 
MN erythrocytes (0.1  ml packed cells/ml of antiserum) the antiserum was absorbed for 15 
minutes at room temperature and centrifuged at 4000 ~.eM for 10 minutes. This was repeated 
until the serum failed to agglutinate B and O erythrocytes on a slide test. 
In addition to the above absorptions the crude preimmune serum was also absorbed with 
blood group A Rh-positive MN human erythrocytes. 
Homologous antiserum: Naturally occurring human anti-A serum of high titer was obtained 
from a blood group O donor. Human anti-B serum was obtained from the Boston Blood-Group- 
ing Laboratory, Boston, Massachusetts. Both these sera were heated at 56°C  for 30 minutes 
prior to titering. 
Characterization of Antibody.-- 
Iteterologous antiserum: (a)  Forssman activity (sheep cell hemolysis) was determined by 
incubating at 37°C 0.1 ml of a 5 per cent suspension of sheep red blood cells, 0.1 ml of a  1:20 
dilution of guinea pig complement, and 0.1 ml of serial twofold dilutions of the absorbed anti- 
serum. Unabsorbed antiserum served as a positive control. (b) ABO isoagglutinin titers were 
ascertained by titration of serial twofold dilutions of the absorbed antiserum using a 2 per cent 
suspension of washed human erythrocytes in saline and in fresh autologous serum. Following 
incubation for 1 hour at room temperature agglutination was checked both macroscopically 
and microscopically. Red blood cells which showed no agglutination were washed in saline and 
incubated for 1 hour at room temperature with sheep anti-rabbit globulin  4 and once again 
examined for agglutination. The sheep antiglobulin used did not agglutinate human washed 
type O Rh-positive erythrocytes. (c) Hemagglutination inhibition was ascertained by neutral- 
izing the antiserum with A and B substance  5 using mixtures of 2" 1, 1 : 1, and 1: 2. The reaction 
was carried on for 15 minutes at room temperature. Serum alone served as a control. The neu- 
tralized serum was diluted 1 : 3 in both saline and in fresh human group A non-secretor serum. 
Serial twofold dilutions were then made in saline of the mixture diluted with saline, and in 
serum with the mixture diluted with serum. A  2 per cent suspension of washed AI and A~ 
human erythrocytes from non-secretors was used as test ceils for tube agglutination and/or 
hemolysis after incubation at room temperature for 1 hour. The indirect antiglobulin test was 
used as described above. (d)  The absorbed antiserum was incubated at 37°C for 60 minutes 
with a panel of human reagent red blood cells for detection of antibody to other erythrocyte 
antigens according to the method outlined by the Ortho Pharmaceutical Corporation. 
2 Division of Biologic Standards, National Institutes of Health, Bethesda, Maryland. 
3 Certified Blood Donor Service, Inc., Jamaica, New  York. 
4 Ortho Pharmaceutical Corporation,  Raritan, New  Jersey. 
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Homologous antiserum: The ABO isoagglutinin titers and the hemagglutination inhibition 
titers were determined in the same manner as described for the heterologous antiserum except 
that rabbit anti-human globulin  4 was employed for the indirect Coombs reagent. 
Preparation of Fluorescein Conjugate.--The method used for coupling the isoagglutinin with 
fluorescein is described in detail by Goldstein, et aL  (4). Briefly, the crude antiserum was 
initially fractionated with cold ammonium sulfate, and the gamma globulin portion then ob- 
tained by means of a DEAE cellulose column. After conjugation of this fraction with fluores- 
cein isothiocyanate (1 mg/200 mg protein) the uncoupled fluorescein radicals and impurities 
were removed on a  sephadex  e column.  Conjugates with  optimal fluorescein:protein (F:P) 
ratios were obtained by gradient elution from a  DEAE cellulose column. The final F:P ratio 
was calculated using a  Beckman DU spectrophotometer at 280 m# and 495 m#. The anti-A 
and the anti-B titers of the conjugated antisera were determined and the conjugate frozen in 
small aliquots and kept at -  20°C until just before use. 
Commercially  prepared,  fluorescein conjugated,  goat  anti-rabbit gamma  globulin  r  was 
absorbed with human liver nuclear sediment prepared according to the method of Hogeboom 
and Schneider (5). The conjugate and liver nuclear sediment were incubated at 37°C for 90 
minutes followed by centrifugation at 10,000 ~M for 10 minutes. The absorbed conjugate was 
stored in 5 ml aliquots at -- 20°C. 
Fluorescent Staining Procedures.-- 
Indirect: Immediately prior to staining the blocks of  albumin-embedded tissue were sec- 
tioned at 8  m# in a  cryostat at  -25°C.  The sections were thawed and air dried at room 
temperature for 10 minutes. The sections were then fixed in acetone for 2 minutes, rinsed in 
0.5 ~r phosphate-buffered saline, pH 7.2, and overlaid with rabbit anti-A. The slides were then 
placed in Petri dishes containing moistened filter paper for 90 minutes at room temperature. 
After 10 minutes of rinsing the excess buffer solution was removed from the slides and the 
sections covered with fluorescein conjugate for 45 minutes. The sections were again rinsed in 
phosphate-buffered saline for 10 minutes and placed in a  50 per cent solution of glycerol and 
phosphate-buffered saline. After 8 to 10 hours the IF preparations were covered with No.  1 
coverslips and sealed with 90 per cent glycerol in phosphate-buffered saline. The preparations 
were examined for fluorescence with a  Leitz ortholux microscope using an Osram I-IBO 200 
mercury arc lamp with appropriate ultraviolet filters (3650 angstrom). 
Direct: Sections of aibumin-embedded tissue were air dried and fixed in acetone for 2 minutes 
and then rinsed in buffered saline for 10 minutes. The sections were then overlaid with the 
fluorescein-conjugated homologous antiserum and placed in Petri dishes containing moistened 
filter paper for 60 minutes at room temperature. The slides were then rinsed in 0.5 M  phosphate- 
buffered saline, pH 7.2, for 10 minutes. The IF preparations were then covered with coverslips 
and examined immediately for fluorescence. 
Routine immunofluorescent controls were run simultaneously under identical conditions. 
These controls are listed in Table L 
Photography.--Permanent records of the observed fluorescence were obtained with Kodak 
35 mm high speed Ektachrome film (daylight type) with an exposure time of 4 minutes. The 
coordinates of the photographed area were carefully recorded so that the area could be rephoto- 
graphed after histologic staining of the fluorescent sections. 
Histologi¢ Counterstaining.--Following photography of the fluorescent areas the slides were 
rinsed in phosphate-buflered saline and  the coverslips floated off.  The sections were  then 
stained with either May-Griinwald-Giemsa (MGG) or with a  PAS stain and then rephoto- 
graphed. 
6 Pharmacia Fine Chemicals, Inc., New York, N.Y. 
7 Microbiological Associates,  Bethesda,  Maryland. 1042  HUMAN  CIIORIONIC VILLUS 
TABLE I 
Immunofluorescent Staining Controls 
Technique 
Directs 
Section only. 
Human anti-A. 
Conjugated human anti-A. 
Human anti-A, then conjugated 
Human anti-A (blocking)... 
Indirect 
Section only. 
Preimmune rabbit serum. 
Absorbed fluorescein conjugate. 
Rabbit anti-A (RBC).. 
Rabbit anti-A (cyst fluid). 
Preimmune rabbit serum -t- conjugate, 
Rabbit anti-A (RBC) -[- conjugate. 
Rabbit anti-A (cyst fluid) "4- conjugate.. 
Observed fluorescence* blood type 
A 
0 
0 
+ 
0 
0 
0 
0 
0 
0 
+ 
+ 
AB 
0 
0 
+ 
0 
0 
0 
0 
0 
0 
+ 
+ 
0 
0 
0 
i 
0 
I 
i 
0 
0 
0 
0 
0 
0 
0 
0 
o 
* Myometrium. 
Identical controls were used with the conjugated human anti-B serum. 
RESULTS 
The absence of  sheep cell  hemolysis indicated  that  all  anti-Forssman activity 
was removed from the crude rabbit  antiserum following  absorption with guinea 
pig kidney suspension. Table II summarizes the results of the direct erythrocyte 
agglutination studies  of the  absorbed homologous and heterologous anfisera. 
The titers represent the last dilution at which agglutination was demonstrable 
microscopically. Table III demonstrates the inhibition of this agglutination in 
the  homologous sera by heterospecific A  and  B  substance.  The evidence for 
inhibition of agglutination in the heterologous sera, as shown in the same table, 
is not as clearly defined.  No hemagglutination was observed with the reagent 
red blood cell panel. 
The results of the direct and indirect IF staining of chorionic villi,  squamous 
epithelium of the cervix, and myometrial vessels are shown in Table IV.  The 
staining results were identical with both the heterologous (cyst fluid and RBC's) 
and the homologous immune sera.  Fig.  1 a illustrates  the typical fluorescence 
of small vessels  in the myometrium from a  patient with blood group A  after 
incubation with fluorescein conjugated human anti-A. Fig. 1 b is the identical 
section counterstained with PAS to provide histologic confirmation of the ob- H.  A. THIEDE, J.  W.  CHOATE, H.  H.  GARDNER, H.  SANTAY  1043 
served fluorescence. IF staining was effectively blocked in the direct technique 
when the sections of myometrium and cervix were preincubated with unlabeled 
antiserum for 60 minutes or when the sections were preimmersed in ethanol for 
20 minutes. The water soluble blood group antigens were readily detected in 
the gastric glands of A secretors (Figs. 2 a and 2 b). No staining was found in 
the specimens of stomach obtained from patients of blood group O. Similarly 
TABLE  II 
Agglutination  Titers of Absorbed A ntisera 
Antiserum 
Rabbit anti-At (erythrocytes) 
Rabbit anti-A (cyst fluid) 
Human anti-A 
Human anti-B 
Medium 
Saline 
FAS* 
Saline 
FAS 
Saline 
FAS 
Saline 
FAS 
AI 
480 
1920 
1280 
1280 
480 
1920 
A2 
960 
480 
B  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
1920  0 
1920  0 
* Fresh Autologous Serum. 
TABLE  III 
Inhibition  of Agglutination of Group AI Erytkrocytes by Specific Blood Group 
Substance* 
Antiserum 
Rabbit anti-A 
Human anti-A conjugate 
Human anti-B conjugate 
Medium 
Saline 
FAS§ 
Saline 
FAS 
Saline 
FAS 
IS 
192  (48) 
768  (1536) 
0  (3072) 
96  (96) 
0  (3072) 
192  (3072) 
II 
48  (0) 
384  (768) 
0  (3072) 
0  (96) 
0  (96) 
192  (384) 
III 
6  (0) 
192  (768) 
0  (96) 
0  (48) 
0  (48) 
96  (192) 
iv 
96  (768) 
192  (192) 
24  (3072) 
768  (768) 
0  (768) 
384  (1536) 
Figures in parenthesis are the indirect Coombs titer. 
* Human group B erythrocytes were used to demonstrate inhibition of the human anti-B 
globulin. 
:~ I represents 2 parts test serum with 1 part A and B substance; II represents equal parts 
of test serum and A and B  substance; HI represents 1 part test serum with two parts A and 
B substance; IV represents test serum only. 
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the blood group antigens were also demonstrated in the collecting tubules and 
endothelium of vessels in the fetal kidney (Table IV). 
Fluorescence was absent in the villous trophoblast of blood group A, AB, B, 
and O term placentas incubated with type A and B antiserum regardless of the 
blood group of the mother or the secretor status of the baby and mother. The 
TABLE IV 
Observed Fluorescence 
Tissue 
Villous trophoblast 
Blood vessels of 
chorionic villi 
Cervix uteri 
Stomach glands 
Blood vessels of 
myometrium 
Fetal kidney 
Blood group 
A 
B 
O 
A 
B 
O 
A 
B 
0 
A 
B 
O 
A 
B 
0 
A 
B 
O 
Rabbit  anti-A 
m 
+ 
+ 
0 
0 
Fluorescent  antiserum 
Human anti-A 
+ 
+ 
0 
0 
+ 
0 
0 
+ 
0 
0 
Human anti-B 
0 
+ 
0 
0 
+ 
0 
-4-  Indicates specific fluorescent staining; 0 indicates no  specific fluorescent staining; 
--  indicates tissue was not studied. 
ABO blood group and secretor status of both mother and fetus for the 2l term 
placentas examined are listed in Table V. 
Of  special  interest  is  the  twin  gestation  (specimen XXXV)  in  which  the 
mother and one fetus were blood group A secretor, while the other fetus was 
blood group O. No specific fluorescence was observed in the vessels  of the chori- 
onic villi  from this placenta but the endothelium of the maternal myometrial 
vessels  revealed  specific  apple-green  fluorescence.  With  rare  exceptions  the 
villous capillaries  of all  the other placentas examined were  equally devoid of 
fluorescence. H.  A.  TtilEDE,  J.  W.  CHOATE~ H.  H.  GARDNER~  H.  SANTAY 
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Specimen 
VI 
VII 
IX 
XXI 
XXXV 
XXXVII 
LXVI 
II 
VIII 
XII 
XV 
XL 
L 
XVI 
XXVII 
XXXII 
LXXVI 
XC 
XCI 
XCV 
XCVII 
Blood group mother/fetus 
A/A 
A/A 
O/A 
A/A 
A/A (Twins) 
A/O 
A/A 
A/O (Twins) 
A/A 
O/O 
O/O 
O/O 
A/O 
O/O 
A/O 
B/B 
O/B 
O/B 
O/B 
A/A 
A/A 
A/A 
O/A 
Secretor status  mother/fetus 
Non-secretor/non-secretor 
Secretor/secretor 
--/Non-secretor 
Non-secretor/non-secretor 
Secretor/secretor 
Secretor/-- 
Secretor/non-secretor 
Secretor/-- 
Secretor/secretor 
Non-secretor/-- 
Secretor/-- 
Secretor/secretor 
--/Secretor 
--/Not obtained 
--/Non-secretor 
Secretor/non-secretor 
Secretor/secretor 
Secretor/secretor 
--/Non-secretor 
Antiserum 
Rabbit  Human 
× 
× 
x 
× 
x 
× 
x 
x 
x 
× 
× 
× 
x 
x 
x 
× 
I 
DISCUSSION 
Our interest in studying the distribution of the ABO antigens in the human 
placenta is not unique. In 1928 yon Oettingen and Witebsky, (6) using group- 
specific antisera, investigated alcoholic extracts of the placenta. They concluded 
that  "the placenta must  be regarded as  a  neutral  organ with  respect to its 
group characteristics." Subsequent early investigators also relying upon extrac- 
tion procedures have added conflicting reports to the literature. Reich (7), in 
1932, confirmed the absence of blood group A antigen in the chorion frondosum 
but  noted  its  presence  in  the  decidua  vera,  decidua  basalis,  and  amnion. 
Witebsky  and  Reich  (8)  also  reported  two  cases  of maternal-fetal  hetero- 
specificity in which the fetal blood group antigen was found in the decidua vera. 
Using saline extracts of placental homogenates and hemagglutination inhibition 
techniques, Freda (9) detected the maternal blood group antigen in the amniotic 
fluid, fetal membranes and decidua vera only when the mother was a secretor, 
and the fetal blood group antigen in the decidua vera only when thefaus was a 1046  HUMAN  CHORIONIC  VILLUS 
secretor. Blood group substances were noted in the placental villi of 7 of the 20 
full term placentas Freda examined. 
In more recent years several workers such as Glynn and Holborow (10),  and 
Szulman (11) have employed the immunofluorescent technique of Coons (12) 
to identify blood group antigens in various tissues.  This method provides a 
sensitive tool for  the  cellular localization of  blood  group  antigens.  The  IF 
technique, however, is susceptible to numerous pitfalls unless the experiments 
are carefully designed to include extensive yet relevant controls. One of the 
foremost controls of this staining method is the demonstration of the specificity 
of the antibody. The agglutination titer and the hemagglutination inhibition 
test (Tables II and III) indicate the serological specificity of the antisera used 
in our experiments. In addition we have employed the fluorescence in endo- 
thelium, squamous epithelium, and glandular secretions as further indication 
of antibody specificity. 
In contrast to the previously described extraction procedures with placental 
homogenates, the fluorescent antibody technique not only obviates the necessity 
of separating the maternal and fetal components of the placenta, but in fact 
permits the simultaneous study of both. This is important in the investigation 
of fetal-maternal incompatibility within the ABO system, a  subject of wide- 
spread interest in both genetic and immunologic areas. 
In the blood group heterospecific pregnancies the stimulation of maternal 
antibody production by the fetal blood group antigen may occur by several dif- 
ferent routes. These include placental transmission of fetal erythrocytes and/or 
the direct passage  of fetal blood group  substance.  The  greatest  increase  in 
maternal antibody titer has been shown to occur 10 to 20 days following de- 
livery (13). This rise may then be due to the passage of amniotic fluid containing 
blood  group  substance  and/or  fetal  erythrocytes during  delivery.  Another 
possible explanation is that the placenta and fetus constantly produce sufficient 
antigens to neutralize the maternal antibody and create an equilibrium. When 
the pregnancy is terminated the source of antigen is removed and the maternal 
titer rises (14). There is, however, disagreement as to the passage of blood group 
substance across the placenta during pregnancy and also as to whether it plays 
any role in immunization at delivery. A potential source of antigen that has not 
been  investigated is  the  trophoblast.  The  transportation  into  the  maternal 
blood stream of these cells which are fetal in origin is known to occur through- 
out pregnancy. Our findings indicate that the villous trophoblast of the term 
placenta is devoid of A  and B  substance. Presumably, therefore, the villous 
trophoblast is not a  direct factor in maternal immunization to the fetal ABO 
blood group antigens during the course of pregnancy. 
First trimester abortion as a  consequence of ABO incompatibility between 
mother and fetus appears to be more than just a possibility. Chung and Morton 
(15),  analyzing 5414 families, showed that in children of type O mothers there H.  A.  THIEDE,  J.  W.  CHOATE,  H.  H.  GARDNER,  H.  SANTAY  1047 
was a statistically  significant decline in frequency of type A and B children with 
increasing parity. The frequency of incompatible children of A and B mothers 
did not apparently decline with increase in parity. In both cases there was a 
significant  overall  deficiency  of incompatible  children  when compared  with 
compatible  matings. From their data they concluded  that "isoimmunization 
by fetal antigens is a major factor in the outcome of pregnancies with type O 
mothers" and "that few gene loci can be as important a cause of fetal death as 
the ABO system." Pertinent to this question is the observation of Kochwa, 
eta/. (16), that the 7S fraction of maternal ABO antibodies crosses the placenta 
without difficulty while the 19S fraction is retained. Hostrup (17) has demon- 
strated A and B substance  in cord serum and believes that the water soluble 
blood group antigen is constantly produced by the fetus in order to neutralize 
the maternal isoantibody. He has shown in vitro that A and B substance  can 
reduce  the fiter of homologous 7S  antibody and inhibit the sensitization  of 
erythrocytes exposed to anti-A (18). Szulman (19), on the other hand, using the 
IF technique,  has studied early embryos for blood group substances  and finds 
that while the epithelial  and endothelial  cell wall antigens are present in the 
earliest  specimens available,  the water  soluble  blood group  antigens are not 
demonstrable before the 8th week postfertilization.  Since fetal death in most 
abortions occurs before the 8th week postfertllization he believes that the lack 
of the protective buffering action provided by the water soluble blood group 
substances prior to this time directly exposes the fetal tissue to maternal iso- 
antibody and leads to the death of the fetus. 
Szulman also noted that the epithelial cell wall blood group antigens disap- 
peared from many organs at a time that coincided with the maturation of the 
organ. Although A and B substances  are not present in the trophoblast of the 
term placenta, it is possible that the trophoblast of early placentas may contain 
the epithelial cell wall blood group antigens. We are currently investigating this 
possibility. 
Perhaps of more interest is our preliminary observation that the blood vessels 
of the term villi from the placentas of A or B newborns, regardless of secretor 
status, apparently contain little or no A and B substance.  Szulman  (19) has 
found that the endothelium of the cardiovascular  system throughout the body 
contains blood  group-specific substance from the  earliest  embryo  (18  nun) 
throughout adulthood. The villous capillaries are thought to originate from the 
mesoderm of the placenta. Since the villous mesoderm and the villous tropho- 
blast have a common origin, i.e., the primitive trophoblast, perhaps it should not 
be surprising to find that the A and B blood group antigens are not expressed in 
both the villous trophoblast and the blood vessels of the chorionic villi of the 
term placenta. If our subsequent investigations of the endothelium support this 
observation,  considerable weight will be added to the contention that the fetus 
and its placenta are immunologically dissimilar. 1048  HUMAN CHORIONIC VILLUS 
SUMMARY 
The chorionic villi of term placentas were examined for A and B blood group 
substance using the IF technique with heterologous and homologous antisera. 
No specific fluorescence was found in either the villous trophoblast or vessels of 
the chorionic villi. The implications of these findings in relation to the question 
of trophoblastic antigenicity are discussed. 
The authors gratefully acknowledge the advice of Dr. Scott N. Swisher and Miss Norma 
Trabold in management of technical problems. We also thank Dr. Scott N. Swisher and Dr. 
John P. Leddy for their assistance in preparation of this manuscript. 
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EXPLANATION OF PLATES 
PLATE 82 
FIo. 1 a. This frozen section of myometrium from a patient of blood group A was 
exposed to fluorescein-conjugated human anti-A serum.  X  425. 
FIo. 1 b. The same section stained with PAS shows that the  areas of fluorescence 
in Fig. 1 a correspond with the capillaries (some of which are indicated by arrows) 
and the intima of the large vein in the center of the photograph.  X  425. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  121  PLATE  82 
(Thiede et al.:  Human chorionic villus) PLATE  83 
FIC. 2 a. This cryostat section of the gastric glands from a  blood group A  secretor 
patient  shows bright  fluorescence in the mucus after exposure  to  fluorescein-labeted 
human anti-A serum.  ×  425. 
FIG. 2 b. The same section stained  with PAS  to provide histological confirmation. 
×  425. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  121  PLATE  83 
(Thiede et al.: Human chorionic villus) 